The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 mutations….
Tag: Lung Cancer Drugs
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most common type of lung…
Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. The University of Barcelona and Hospital…
Pairing Lung and Breast Cancer Drugs More Effective in Killing Cancer Cells
According to the new study, if the drugs used to treat breast and lung cancer are combined, they overcome resistance to treatment. The study is published in the Journal Oncogene and was…
Is Lung Cancer Curable?
Can lung cancer be cured? Is lung cancer curable if detected early? Is lung cancer treatable at any stage? Can surgery or chemotherapy cure it? These are some of the questions that…
Tecentriq Plus Chemotherapy Approved for Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Tecentriq, in combination with carboplatin and etoposide for the first-line treatment of patients suffering from extensive-stage small cell lung cancer. Out of total lung…
Research: Scientists Discover New Drug Target for Lung Cancer
A group of researchers at the University of Cambridge have identified lung squamous cell carcinoma (LUSC) cells containing high amounts of protein called BCL11A. LUSC occurs when abnormal lung cells form a…
Drug: Nivolumab to Treat NSCLC
About Nivolumab Nivolumab or Opdivo is a prescription drug used for the treatment of advanced non-small cell lung cancer. It is given to those patients where lung cancer has spread and platinum-based…